Mononucleosis Diagnostic Market Challenges, Business Overview and Forecast Research Study 2024-2031
The global mononucleosis diagnostic market is anticipated to witness a promising trajectory, with a projected value of USD 3.2 billion by 2030. This translates to a steady compound annual growth rate (CAGR) of 8.6% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 1.7 billion in 2022.
Key Players
The major key players are Daiichi, Digene, Hemagen, Meridian, Gene-Tac, Biotest, Abbott Laboratories, Bio-Rad, Genzyme, Roche, Johnson & Johnson, Becton Dickinson, Diasorin, Beckman Coulter, and Others.